GYRO - Kewajiban jangka dawa marang modal Gyrodyne LLC

Gyrodyne LLC - logo grafis emiten GYRO

Gyrodyne, LLC is a developer of medical and commercial centers featuring conservative management and a stable employee benefits package. Operational management of New York properties has been outsourced to third-party contractors to optimize staffing. The long-term debt-to-equity ratio reflects financial stability, with the 0.00 mark serving as a key metric. Gyrodyne, LLC is currently completing a strategic asset liquidation by selling off land parcels.

Gyrodyne LLC (GYRO): Utang jangka dawa marang modal saka 04.07.2022 nganti 28.10.2026
Produk merek Gyrodyne

Supply localization and a focus on medical real estate provide Gyrodyne, LLC with high operational resilience. This indicator compares liabilities with a maturity of more than one year against the issuer's total equity. It is critical for investors to evaluate this balance to distinguish market volatility from a genuine increase in debt load. Low values minimize default risk, although excessive conservatism may limit expansion rates. The long-term credit leverage trend allows for an objective assessment of the business's financial autonomy.